The Tenofovir Trial in Cambodia In 2004 a randomized trial by investigators from the United States and Australia was planned to assess the safety and efficacy.

Slides:



Advertisements
Similar presentations
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Advertisements

Service User Discussion
Learning and Empowerment: “Key Issues in Strategies for HIV/AIDS Prevention” March 1-5, 2004, Chiang Mai Presented by Dr. Pum Sophiny, Program Officer.
Practical Ethical Issues in HIV Research in South Africa William M Pick Acting President Medical Research Council & Professor Emeritus University of the.
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.
STANDARD Anything serving as a type or pattern to which other like things must conform (Stedman’s Medical Dictionary) STANDARD OF CARE The level at which.
M&E Framework for Programmes for Most-at-Risk Populations
VIETNAM NETWORK OF SEX WORKERS TOWARDS A BETTER FUTURE FOR SEX WORKERS! MELBOURNE, 24 JULY 2014.
Cancer Clinical Trials: The Basics. 2 What Are Cancer Clinical Trials? Research studies involving people Try to answer scientific questions and find better.
How You Can Be an Advocate for Clinical Trials in Your Community.
"HIV Cure" 101 Workshop Current Community Questions and Concerns about “HIV Cure” Bill Whittaker National Association of People with HIV Australia.
2010 FIFA World Cup and HIV/AIDS “Football and sex belong together”
TB/HIV COMMUNITY MOBILIZATION IN AFRICA: Ongoing activities, achievements and challenges Paula Akugizibwe, AIDS and Rights Alliance for Southern AFrica.
Part 2 Gender and HIV/AIDS HIV/AIDS IS A GENDER ISSUE BECAUSE: I Although HIV effects both men and women, women are more vulnerable because of biological,
The International Community of Women Living with HIV/AIDS “by and for” HIV positive women.
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
Ethical Issues in Clinical Trials in Developing Countries Carl H. Coleman Professor of Law Director, Health Law & Policy Program Seton Hall Law School.
Domestic violence-not with us! 27 June -5 July 2011 Poland, Nowy Sacz “SOS - Families at risk” Foundation VARNA, BULGARIA.
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Foster/Adoptive/ Biological Parents On LINE Crisis Intervention System Foster/Adoptive/ Biological Parents On LINE Crisis Intervention System Being Presented.
Systems Advocacy: helping systems help families BETH OLSON, MSW.
Raising Consciousness Creating Awareness Behaviour Change Communication CHETNA STRC Ahmedabad.
Supporting community action on AIDS in developing countries.
From choice, a world of possibilities HIV Prevention Report Cards for Sex Workers © IPPF EN/Layla Aerts/Kazakhstan 2013 Lena Luyckfasseel 20 July 2014.
Ethical considerations on HIV and Syphilis research in indigenous communities in Peru Instituto Nacional de Salud Ministerio de Salud PERÚ Centro Nacional.
Learning journey Part 1: Welcome and introduction Part 2: Concepts, evidence, and good practice: Addressing gender-based violence and engaging men and.
BY GINO JOSE FUNDAMENTS OF STD/HIV/HCV COUNSELING.
HIV/AIDS VACCINE AWARENESS Vaccine 101 Jeremiah Brewer Health and Training Educator African – Americans Reach and Teach Health Ministry.
Work group #2 Community based services and information.
ILGA, Community involvement in prevention trials Gus Cairns Policy Working Group, European AIDS Treatment Group: Editor, HIV Treatment.
COMMUNITY CONSULTATION: LESSONS LEARNED IN HIV COMMUNITY-BASED RESEARCH Ronald P. Strauss, D.M.D., Ph.D. University of North Carolina at Chapel Hill.
19-20 JULY 2012 WASHINGTON D.C Community Mobilization & Activism Community Mobilization & Activism.
Washington D.C., USA, July 2012www.aids2012.org Treatment Monitoring & Advocacy Project: “Missing the Target Report Series” Othoman Mellouk ITPC-NA/ALCS.
Principles and Practices: The implementation of ethical guidelines for research on HIV Geneva, 2-3 June 2003 Ethical guidelines for HIV vaccines: Generic.
Keep your promise to women and girls Violence against Women and Girls in National AIDS plans.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
1 People who use drugs, HIV, and human rights The Lancet : HIV in people who use drugs Vienna, 20 July 2010 Ralf Jürgens Joanne Csete, Joe Amon Steven.
Chief Inspector Graham Goulden Scottish Violence Reduction Unit.
Organization of African Unity Pandemic Report. 1. Denial of the Problem For many years, people denied that AIDS was a big problem. Particularly in the.
HOW ARE MDP PREPARING COMMUNITIES AT TRIAL SITES? MDP301.
Participating in an HIV vaccine trial By Jo Robinson, London, UK.
It began here: Nothing about us without us
Applicability of principles Reidar K. Lie, MD, PhD Department of Clinical Bioethics, NIH and University of Bergen, Norway.
Identifying current and potential ethical challenges and Dilemmas in HIV prevention Research Ethics in clinical research: challenges linked.
Easy Read Summary Mental Capacity Act Mental Capacity Act A Summary The Mental Capacity Act 2005 will help people to make their own decisions.
Thorny Issues in HIV Vaccine Trials Saul Walker Policy Advisor IAVI.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 8: HEALTH CARE WORKER RIGHTS AND OBLIGATIONS Insert.
BDH Discovering Tomorrow’s Healthcare Solutions Today Clinical Research Services, Inc. Basil Halliday, M.Sc. President & CEO BDH Clinical Research Services.
Rationalizing the New Healthcare Paradigm Scientific Agenda vs. Patient Imperatives Scientific Agenda vs. Patient Imperatives.
AN INTERNATIONAL MULTI-CENTRE, RANDOMISED, DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF 0.5% AND 2% PRO 2000 GELS FOR.
1 Lambaa.S Member of parliament of Mongolia, Minister of Health National Conference on HIV/AIDS Hotel Chingis, Dec.2-3, 2008 Government role in prevention.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Study on Transgender Women’s Health and Well-being in Ho Chi Minh City, Vietnam (TransVN Study) Le.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Healthy Relationships Health 9. Health Relationships Define relationships –A bond or connection you have with other people How do relationships have a…
Clinical Trials The Way We Make Progress Against Disease.
Washington D.C., USA, July 2012www.aids2012.org Is the scientific and programming community ignoring condoms— the visible yet invisible method proven.
YONECO SRHR POLICY. SHAREFRAME CONFERENCE Salima - Malawi Mr. Samuel Bota Board Member.
Collaborative Effort of HIV, Domestic Violence and Homeless Service Organizations to Develop Integrated Services as Strategy for HIV Risk Reduction for.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
The tipping point: When do placebos become unethical? Bridget Haire.
Some questions around efficacy and effectiveness Gus Cairns NAM Publications
Pre-exposure Prophylaxis (PrEP) for HIV Prevention: What’s the Future? Joanne Stekler, MD MPH Assistant Professor of Medicine University of Washington.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
TransIT The Transgender Implementation Tool for the WHO key population guidelines.
INTERNATIONAL AIDS SOCIETY Stakeholder consultation to address issues related to tenofovir prophylactic research SUMMARY MEETING UPDATE, MAY 2005, SEATTLE,
PrEP introduction for Adolescent Girls and Young Women
‘ Children as Agents of Social Change  Opening Seminar
Presentation transcript:

The Tenofovir Trial in Cambodia In 2004 a randomized trial by investigators from the United States and Australia was planned to assess the safety and efficacy of Tenofovir as pre exposure prophylaxis for HIV in HIV negative female sex workers in Cambodia. The trial was to recruit 960 women but in July 2004 protests led by sex workers in Cambodia and activists at the XV International AIDS Society conference in Bangkok, brought worldwide media attention to claims that the trial was unethical in several ways. Lack of ongoing health care for participants was a particular focus. As a result of the protests the Cambodian Prime Minister closed the trial early, 400 participants had been recruited.

Everyone agrees that … Trial volunteers who are recruited because they are seen as likely to practice a particular risk behaviour should receive the best proven measures to help them reduce their risk of acquiring HIV infection from that behaviour BUT What are the best proven HIV prevention measures ? Were they already in place in Cambodia - and if not why not ? If they are in place does it mean the researchers don’t have to provide anything extra ? Informed Consent should be obtained from every participant. BUT What is informed consent ?

“ We were told that we can contribute to saving humanity, why should we do that, what has humanity done for us ? … sold us…discriminated against us …raped us…kept us powerless. Humanity has denied our humanity, why are we asked to contribute. ” There are HUMAN RIGHTS in the USA, how about ours in CAMBODIA? Violations of sex workers human rights : potholes on the road to a vaccine ?

Video 10 minute film about the WNU campaign

Listening for Researchers “ I am not worried about HIV.I use condoms. What if my arm drops off or I have a kid with two heads ? So you will encourage condom use, even provide them, but to get results you need us to have unprotected sex ….run that by me again What is being done to give HIV + sex workers access to what all HIV citizens are already entitled to ? You turned up to talk to us with the very people that run other corrupt, violent abusive HIV programs here - 100% CUP and “rescues” of alleged trafficking victims - why would we trust you ? ” The 100% Condom use program - HIV prevention for sex workers in Cambodia ?

The key questions Should people that become HIV infected while enrolled in a trial as a result of risky behaviour or exposures that they cannot avoid should HIV treatment be provided. If so, at what level, for how long ? If trial participants are physically harmed by the product being tested should they receive care and compensation? Through what process ? If the product is proved effective should trial participants or their communities receive that product even if their government or health insurer won’t pay for it ?

Community People were arguing about different things, all of them with broader implications for health research. One issue is the ambiguous definition of the word “community.” Is it people enrolling in a trial, the surrounding population, NGOs in the region or nation, activists 4000 miles away? How are all those voices to be heard and responded to in a meaningful way? AIDS VACCINE ADVOCACY COALITION

Recommendations Better coordination between the disparate trials their multiple sponsors, trial participants and their communities Protections and benefits for trial participants at all trial sites that include treatment for HIV infection high quality prevention interventions compensation for physical harm caused by participation in research. Capacity building for researchers, trial sponsors and sex worker communities to build understanding of the issues Renewed systems for ethical approval and monitoring of trials.

Add logos